[Correlations between skin autofluorescence and conventional glycemic markers in patients with diabetes]
- PMID: 26256498
- DOI: 10.1556/650.2015.30229
[Correlations between skin autofluorescence and conventional glycemic markers in patients with diabetes]
Abstract
Introduction: Skin autofluorescence has a well-known significance for screening diabetes and early diagnosis of vascular complications. It predicts cardiovascular events better than hemoglobin A1c, hence skin autofluorescence is a marker of cumulative tissue glycemic load whereas hemoglobin A1c reflects changes occurring in the previous 6-8 weeks.
Aim: The aim of the authors was analyze the relationship between skin autofluorescence and conventional glycemic markers in patients with diabetes.
Method: Skin autofluorescence measurements were performed in 2010 in 18 patients (10 men and 8 women with normal glomerular filtration rate; age, 61.4±13.8 years) with long term follow-up (2624 months, 476 laboratory results). Relationships between skin autofluorescence values and fasting blood glucose, hemoglobin A1c levels and metabolic parameters obtained before and after skin autofluorescence measurements were analysed using Spearman rank test.
Results: The average skin autofluorescence value was 2.88±0.65 arbitrary units. There were no significant correlations between skin autofluorescence and hemoglobin A1c levels obtained before (7.84±1.08%, p = 0.07) and after the skin autofluorescence measurements (7.45±1.18%, p = 0.71). Skin autofluorescence values also failed to show relationship with fasting blood glucose obtained before (p = 0.09) and after (p = 0.29) the skin autofluorescence measurements.
Conclusions: In patients with diabetes skin autofluorescence may provide novel information about glycemic burden. Skin autofluorescence values (which may presumably provide a more accurate estimation of the cardiovascular risk) do not correlate with hemoglobin A1c and fasting blood glucose.
Keywords: bőr-autofluoreszcencia; cardiovascular risk; cardiovascularis kockázat; hemoglobin A1c; hemoglobin-A-1c; skin autofluorescence.
Similar articles
-
Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.J Gerontol A Biol Sci Med Sci. 2015 Jul;70(7):841-6. doi: 10.1093/gerona/glu243. Epub 2015 Jan 14. J Gerontol A Biol Sci Med Sci. 2015. PMID: 25589479
-
Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction.Diabet Med. 2012 Jun;29(6):726-33. doi: 10.1111/j.1464-5491.2011.03562.x. Diabet Med. 2012. PMID: 22211881
-
Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue.Diabet Med. 2011 Jul;28(7):818-23. doi: 10.1111/j.1464-5491.2010.03217.x. Diabet Med. 2011. PMID: 21204956
-
Applications and pitfalls of hemoglobin A1C and alternative methods of glycemic monitoring.J Diabetes Complications. 2020 Aug;34(8):107585. doi: 10.1016/j.jdiacomp.2020.107585. Epub 2020 Apr 23. J Diabetes Complications. 2020. PMID: 32553575 Review.
-
Skin autofluorescence of advanced glycation end-products, glycemic memory, and diabetes complications.Diabetes Metab. 2025 Jan;51(1):101600. doi: 10.1016/j.diabet.2024.101600. Epub 2024 Dec 6. Diabetes Metab. 2025. PMID: 39647777 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials